These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP. Harris A, Hendrie D, Bower C, Payne J, de Klerk N, Stanley F. Med J Aust; 1994 Apr 18; 160(8):483-8. PubMed ID: 8170423 [Abstract] [Full Text] [Related]
4. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India. Gupta M, Prinja S, Kumar R, Kaur M. Health Policy Plan; 2013 Jan 18; 28(1):51-61. PubMed ID: 22407018 [Abstract] [Full Text] [Related]
5. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation. Platonov AE, Griffiths UK, Voeykova MV, Platonova OV, Shakhanina IL, Chistyakova GG, Robertson SE, Moscow Hib Study Team. Vaccine; 2006 Mar 20; 24(13):2367-76. PubMed ID: 16413949 [Abstract] [Full Text] [Related]
8. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, Sur D, Anh DD, Agtini M, Bhutta Z, DOMI Typhoid Economics Study Group. Vaccine; 2008 Nov 25; 26(50):6305-16. PubMed ID: 18835415 [Abstract] [Full Text] [Related]
9. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines. Eskola J. J Intern Med; 2010 Mar 25; 267(3):241-50. PubMed ID: 20201918 [Abstract] [Full Text] [Related]
10. Age- and cause-specific childhood mortality in Lombok, Indonesia, as a factor for determining the appropriateness of introducing Haemophilus influenzae type b and pneumococcal vaccines. Nelson CM, Sutanto A, Gessner BD, Suradana IG, Steinhoff MC, Arjoso S. J Health Popul Nutr; 2000 Dec 25; 18(3):131-8. PubMed ID: 11262765 [Abstract] [Full Text] [Related]
11. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Wilopo SA, Kilgore P, Kosen S, Soenarto Y, Aminah S, Cahyono A, Ulfa M, Tholib A. Vaccine; 2009 Nov 20; 27 Suppl 5():F67-74. PubMed ID: 19931723 [Abstract] [Full Text] [Related]
13. Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain. Díez-Domingo J, Pereiró I, Morant A, Gimeno C, San-Martín M, González A, Group for the Study of Invasive Diseases. J Infect; 2001 May 20; 42(4):257-60. PubMed ID: 11545568 [Abstract] [Full Text] [Related]
15. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique. Griffiths UK, Hutton G, Das Dores Pascoal E. Health Policy Plan; 2005 Jan 20; 20(1):50-9. PubMed ID: 15689430 [Abstract] [Full Text] [Related]
17. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children. Chotivitayatarakorn P, Chotivitayatarakorn P, Poovorawan Y. Southeast Asian J Trop Med Public Health; 2010 Jan 20; 41(1):114-25. PubMed ID: 20578490 [Abstract] [Full Text] [Related]